Komatsu, H., Enomoto, M., Shiraishi, H., Morita, Y., Hashimoto, D., Nakayama, S., . . . Fujimoto, S. (2020). Correction to: Severe hypoglycemia caused by a small dose of repaglinide and concurrent use of nilotinib and febuxostat in a patient with type 2 diabetes. Diabetol Int.
Dyfyniad Arddull ChicagoKomatsu, Hitomi, et al. "Correction To: Severe Hypoglycemia Caused By a Small Dose of Repaglinide and Concurrent Use of Nilotinib and Febuxostat in a Patient With Type 2 Diabetes." Diabetol Int 2020.
Dyfyniad MLAKomatsu, Hitomi, et al. "Correction To: Severe Hypoglycemia Caused By a Small Dose of Repaglinide and Concurrent Use of Nilotinib and Febuxostat in a Patient With Type 2 Diabetes." Diabetol Int 2020.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.